Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study.

Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study. Semin Oncol. 1997 Feb; 24(1 Suppl 2):S2-13-S2-16.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Cyclophosphamide
Disease-Free Survival
Female
Humans
Neoplasm Staging
Ovarian Neoplasms
Paclitaxel
Prospective Studies

authors with profiles

Michael H. Davidson